4d Molecular Therapeutics, Inc. · NASDAQ:FDMT

Bizily Scott sold 584 4d Molecular Therapeutics, Inc. shares (Form 4)

Traded Sep 1, 2026 · Filed Sep 3, 2026

On Sep 1, 2026, Bizily Scott (Chief Legal Officer) sold 584 4d Molecular Therapeutics, Inc. shares at US$14.00 for US$8,176 under a trading plan, leaving 8,617 shares. Filed Sep 3, 2026 (Form 4).

Sold
584 shares
Price
US$14.00
Value
US$8,176
Holding after
8,617 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Legal Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 1, 2026Common StockOption exercise584US$6.499,201Direct
Sep 1, 2026Common StockSale584US$14.008,617Direct

Source

View original at SEC

Related